LifeStance Health Group, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.4B | $1.3B | $1.1B | $859.5M | $667.5M |
| Selling, general & administrative | $382.2M | $363.1M | $410.8M | $378.0M | $433.7M |
| Operating expenses | $1.4B | $1.3B | $1.2B | $1.1B | $953.9M |
| Operating income | $24.1M | -$31.6M | -$189.1M | -$210.2M | -$286.4M |
| Interest expense | $11.7M | $26.5M | $21.2M | $19.9M | $38.9M |
| Pretax income | $12.4M | -$57.6M | -$206.6M | -$232.7M | -$333.1M |
| Income tax expense | $2.7M | -$170,000 | -$20.3M | -$17.2M | -$25.9M |
| Net income | $9.7M | -$57.4M | -$186.3M | -$215.6M | -$307.2M |
| Balance Sheet | |||||
| Cash and equivalents | $248.6M | $154.6M | $78.8M | $108.6M | $148.0M |
| Current assets | $416.2M | $312.5M | $225.7M | $233.2M | $266.5M |
| Total assets | $2.2B | $2.1B | $2.1B | $2.2B | $1.9B |
| Current liabilities | $252.0M | $228.9M | $202.9M | $176.0M | $116.8M |
| Total liabilities | $682.9M | $672.0M | $681.0M | $655.1M | $382.1M |
| Total debt | — | $279.8M | $280.3M | $225.1M | $157.4M |
| Stockholders' equity | $1.5B | $1.4B | $1.4B | $1.5B | $1.5B |
| Cash Flow Statement | |||||
| Cash from operations | $146.2M | $107.3M | -$16.9M | $52.8M | $9.4M |
| Depreciation and amortization | $41.6M | $40.7M | $37.4M | $28.9M | $15.1M |
| Stock-based compensation | $74.7M | $76.2M | $99.4M | $187.4M | $259.4M |
| Capital expenditure | $36.1M | $21.6M | $40.5M | $79.3M | $94.5M |
| Free cash flow | $110.0M | $85.7M | -$57.4M | -$26.5M | -$85.1M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 387.8M
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.